Healthcare -
Biotechnology - NASDAQ - US
$ 25.535
2.55 %
$ 279 M
Market Cap
-1.07
P/E
CDTX - STOCK-BASED COMPENSATION
Stock-based Compensation CDTX - Cidara Therapeutics, Inc.
3.06 M
LAST VALUE
-12.67%
2 YEAR CAGR
-11.72%
5 YEAR CAGR
75.57%
10 YEAR CAGR